QDST™ is an innovative product designed to take full advantage of solid and liquid media based drug susceptibility testing and to identify susceptibility to 13 different drugs in 7 days using our patented dedicated microfluidic chip.

Drug Susceptibility Test for M. tuberculosis in 7 days

Time matters

The QDST provides results within 7 days whereas conventional methods requiring 28 – 42days.

Handles up to 120 samples

HIGH CAPACITY

M. tuberculosis drug susceptibility test platform reports optimal drugs with susceptible and resistance in 7 days

FAST

Random access capability 

RANDOM ACCESS

Minimal hands-on time to operate

Stand-alone with embedded PC

SIMPLE

No risk of M. tuberculosis exposure to technician

SAFETY

Reliable and efficient integration with the hospital information

LIS

  •  Implementation of M. tuberculosis treatment efficacy and reduction of side effects of drug through a rapid and accurate diagnosis 

  •  Reduction of cost and drug resistance through avoiding drugs misuse or overuse

QDST™ is an innovative product designed to take full advantage of solid and liquid media based drug susceptibility testing and to identify susceptibility to 13 different drugs in 7days using our patented dedicated microfluidic chip.

QDST™ liquid culture DST

Culture on liquid media

1 week DST

QDST™ solid culture DST

Culture on solid media

Conventional solid culture DST

Culture on solid media

1 week DST

6 weeks DST

0

1

2

3

4

5

6

7

8

9

10

weeks

Fully automated incubating, imaging, analysis with 120 random access
  • Handles up to 120 samples

  • 37℃ incubation

  • Time-lapse imaging for checking cell growth 

QDST  stage

24 well plate containing up to two concentrations of 13 drugs. 

  • A microfluidic drug Susceptibility system that produces 4 first-line drugs and 9 second-line drugs in 7 days using imaging

  • Critical concentration for S/R determination

  • Low and High-level resistance detection of primary antibiotics at multiple concentrations

  • Customizable: New drugs can be easily added

Dried antibiotics

Inlet of sample

Automated Drug Susceptibility Test system

  • Handles up to 120 samples

  • 37℃ incubation

  • Time-lapse imaging for checking cell growth

Single bacterial cells under various antimicrobial
conditions

  • Direct observation of bacteria cell growth

  • M. tuberculosis Drug Susceptibility Test using our patented microfluidic agarose channel panel 

Cell tracking and analysis software

  • Single cell tracking

  • Susceptibility/Resistance based on critical concentration

3 level safety

Immobilized MTB in agarose, sealing film, cover with safety lock

Reporting the susceptibility by a proprietary algorithm

and database

  • Reporting susceptible results by proprietary algorithm and database

  • Reliable and efficient integration of LIS

  • S/R(Susceptible and Resistant) determination based on database and expert rules

HEADQUARTER

Address : 105, B1, Center for medical innovation, Seoul National University Hosipital 71, Daehak-ro, Jongno-gu, SEOUL,

Rep. of KOREA (03082)

E-Mail : contact@quantamatrix.com

TEL. Corporate Management: +82-2-763-8820 

Sales & Marketing: +82-2-6947-7611,2

QUANTAMATRIX EUROPE

Address : Villejuif Bio Park - 1 Mail du Professeur Georges Mathé, 94800 Villejuif - France

E-Mail : contact-europe@quantamatrix.com

Sales & Marketing: +33 (0) 1 45 21 18 65

© Copyright QuantaMatrix 2018. All Rights Reserved